You have 9 free searches left this month | for more free features.

T-Reg

Showing 1 - 25 of 8,883

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Charleston (Simvastatin 40mg)

Recruiting
  • Prostate Cancer
  • Simvastatin 40mg
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Nov 30, 2022

Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

Not yet recruiting
  • Islet Transplantation
  • Infusion of recipient T regulatory cell
  • Infusion of concomitant Donor Derived Vertebral Bone Marrow
  • Palo Alto, California
    Stanford University
Jul 25, 2023

Kidney Transplant Rejection, End Stage Renal Disease Trial in Belgium, Netherlands, United Kingdom (TX200-TR101)

Recruiting
  • Kidney Transplant Rejection
  • End Stage Renal Disease
  • TX200-TR101
  • Leuven, Belgium
  • +4 more
Sep 30, 2022

Type1diabetes Trial in Stockholm, Uppsala (Autologous T regulatory cells)

Active, not recruiting
  • Type1diabetes
  • Autologous T regulatory cells
  • Stockholm, Sweden
  • +1 more
Mar 25, 2021

Chronic GVHD Trial in Bologna (T reg DLI)

Recruiting
  • Chronic Graft Versus Host Disease
  • T reg DLI
  • Bologna, BO, Italy
    University Hospital St. Orsola-Malpighi Polyclinic
Jan 14, 2021

Metastatic Melanoma Trial in Louisville (Ipilimumab)

Terminated
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Paroxysmal Supraventricular Tachycardia Trial in Worldwide (Etripamil NS)

Active, not recruiting
  • Paroxysmal Supraventricular Tachycardia
  • Etripamil NS
  • Gilbert, Arizona
  • +123 more
Nov 21, 2022

Hematological Malignancies, Regulatory T Cell Depletion, Relapse Trial in Creteil (T-reg depleted DLI, Standard DLI)

Recruiting
  • Hematological Malignancies
  • +2 more
  • T-reg depleted DLI
  • Standard DLI
  • Creteil, France
    Henri Mondor Hospital
Nov 19, 2020

Colitis Ulcerative Trial in Worldwide (SAR443122, Placebo)

Recruiting
  • Colitis Ulcerative
  • Los Alamitos, California
  • +5 more
Jan 20, 2023

Chronic Spontaneous Urticaria Trial in Worldwide (rilzabrutinib, )

Recruiting
  • Chronic Spontaneous Urticaria
  • Caba, Buenos Aires, Argentina
  • +66 more
Jan 20, 2023

Plasma Cell Myeloma Recurrent Trial in Australia, Chile (Isatuximab IV, Isatuximab SC, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma Recurrent
  • Isatuximab IV
  • +3 more
  • Salt Lake City, Utah
  • +33 more
Jan 16, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Pembrolizumab (Keytruda®), SAR444245 (Thor-707), Cetuximab

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Pembrolizumab (Keytruda®)
  • +2 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

Not yet recruiting
  • Lupus Nephritis
  • Type 1 Diabetes Mellitus
  • autologous adoptive T regulatory cell transfer.
  • Cairo, Egypt
    Ain shams university, faculty of medicine
Sep 30, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (IMU-838 tablets, Placebo matching IMU-838 tablets)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • IMU-838 tablets
  • Placebo matching IMU-838 tablets
  • Altamonte Springs, Florida
  • +28 more
Jul 29, 2022

Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)

Completed
  • Neurodermatitis
  • Dupilumab SAR231893
  • +4 more
  • Fort Smith, Arkansas
  • +56 more
Dec 2, 2021

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Asthma Trial in Worldwide (Dupilumab SAR231893)

Recruiting
  • Asthma
  • Dupilumab SAR231893
  • Ciudad de Buenos Aires, Buenos Aires, Argentina
  • +45 more
Jan 16, 2023

Sjögren's Syndrome Trial in Worldwide (SAR441344, Placebo)

Recruiting
  • Sjögren's Syndrome
  • DeBary, Florida
  • +38 more
Dec 29, 2022

End Stage Renal Disease Trial in Chicago (Expanded Tregs)

Completed
  • End Stage Renal Disease
  • Expanded Tregs
  • Chicago, Illinois
    Northwestern University Comprehensive Transplant Center
Oct 4, 2019

Lupus Erythematosus, Systemic Trial in Worldwide (VIB7734, Placebo)

Active, not recruiting
  • Lupus Erythematosus, Systemic
  • La Jolla, California
  • +88 more
Jan 10, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (Placebo, Volasertib, Cytarabine)

Completed
  • Leukemia, Myeloid, Acute
  • Placebo
  • +2 more
  • Los Angeles, California
  • +121 more
Oct 25, 2021

Covid19 Trial in Worldwide (Novaferon, Placebo)

Recruiting
  • Covid19
  • Novaferon
  • Placebo
  • Bahia Blanca, Argentina
  • +87 more
Jun 1, 2022

COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Itepekimab SAR440340
  • Placebo
  • Palm Springs, California
  • +231 more
Dec 19, 2022

COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Dupilumab SAR231893
  • +4 more
  • Andalusia, Alabama
  • +286 more
May 11, 2022

Drug Concentration to Predict Recapture of Response in Crohn's

Completed
  • Crohn's Disease
    • Calgary, Alberta, Canada
    • +23 more
    Mar 5, 2021